• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 22, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Conformational equilibria in GPCRs provides critical clues about activation mechanisms

Bioengineer by Bioengineer
March 19, 2021
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Cell

A multinational research team led by Dr. Adnan Sljoka (RIKEN), Prof. R. Scott Prosser (Univ. of Toronto) with collaborations with Dr. Duy Phuoc Tran and Prof. Akio Kitao (Tokyo Tech) and Prof. Roger K. Sunahara (Univ. of California San Diego) has carried out experimental and computational studies, revealing key steps associated with the activation of the human adenosine A2A receptor (A2AR). A2AR is a member of superfamily of receptors called G protein-coupled receptors (GPCRs) (major drug targets) which engage the G protein and initiates cell signaling. The research team discovered that A2AR is represented by at least two inactive conformations and three active conformations whose populations are dependent on ligands and activation states of G protein, and that communication between receptor and G-protein is important for activation and signalling. This study is expected to allow researchers to reach new level of insight in GPCR activation and disease mechanism.

Background

GPCRs affect almost every aspect of human physiology, where 35% of all approved drugs act on GPCRs. In most cases, GPCRs are situated in the plasma membrane that surrounds the cell while the drug or ligand (such as hormones and neurotransmitters) that acts on the GPCR binds to an extracellular pocket. Activation is then transduced across the receptor, resulting in complexation with proteins on the cell interior. Since input arrives at the cell exterior and initiates signalling pathways inside the cell, this makes GPCRs useful in pharmacology as the drug in many cases need not enter the cell. However, GPCRs activations relate to dynamic events and key intermediate states that arise between the time that a ligand binds and when the G protein is activated. Capturing conformational dynamics of GPCRs and description of intermediate states and its role in activation and signalling has been a formidable challenge, which has hampered progress in understanding activation mechanisms of GPCRs.

Overview of Research Achievement

Using Fluorine-nuclear magnetic resonance (19F-NMR), mathematical rigidity theory, and molecular dynamics simulations, the international research team has discovered the key mechanism of activation of the human adenosine A2A receptor (A2AR) as it proceeds through signaling pathway. A2AR (also known as caffeine receptor as it is deactivated by caffeine) is a well-known GPCR that is distributed in the nervous system, platelets, immune cells, lungs, heart, and the vasculature. A2AR drugs have been developed to address wound healing, vascular diseases, including atherosclerosis, restenosis, and platelet activation, in addition to inflammation and cancer. Thus, understanding its functional states associated with receptor signaling can yield new opportunities in pharmacology and general understanding of GPCR activation mechanisms. The researchers focused on biasing key conformational states of A2AR by complexing it with G protein and different ligands to better understand signal transduction and receptor activation. F-NMR showed that A2AR is represented by at least two inactive conformations and three active conformations associated with signaling pathway whose populations are dependent on ligands engagement and G protein interactions (Fig2). Research team also used Molecular Dynamics simulations to create a structure of A2AR bound to heterotrimer G-protein complex (performed by Kitao lab), where rigidity theory methods of Sljoka identified an activation pathway where A2AR initiates communication with the G-protein which traverses the receptor’s ligand binding site and G-protein (Fig3). Gβγ subunit was discovered to serve as a critical domain for facilitating signaling and activation. Understanding the activation mechanism and functional states of A2AR signaling may provide new opportunities for drug discovery.

Future Development

While the current study provides unprecedented resolution of key functional states associated with receptor signaling, future studies will no doubt focus on other key domains, providing a more comprehensive picture of the activation process.

###

About Tokyo Institute of Technology

Tokyo Tech stands at the forefront of research and higher education as the leading university for science and technology in Japan. Tokyo Tech researchers excel in fields ranging from materials science to biology, computer science, and physics. Founded in 1881, Tokyo Tech hosts over 10,000 undergraduate and graduate students per year, who develop into scientific leaders and some of the most sought-after engineers in industry. Embodying the Japanese philosophy of “monotsukuri,” meaning “technical ingenuity and innovation,” the Tokyo Tech community strives to contribute to society through high-impact research.
https://www.titech.ac.jp/english/

Media Contact
Emiko Kawaguchi
[email protected]

Original Source

https://www.titech.ac.jp/english/news/2021/049254.html

Related Journal Article

http://dx.doi.org/10.1016/j.cell.2021.02.041

Tags: Biology
Share12Tweet8Share2ShareShareShare2

Related Posts

APS PRESS Unveils Third Edition of Cotton Industry’s Premier Diagnostic Reference

APS PRESS Unveils Third Edition of Cotton Industry’s Premier Diagnostic Reference

August 22, 2025
Metabolic Modeling Reveals Yeast Diversity for Enhanced Industrial Biotechnology

Metabolic Modeling Reveals Yeast Diversity for Enhanced Industrial Biotechnology

August 22, 2025

Mechanisms of Amino Acid Transport in Plants Unveiled

August 22, 2025

Unraveling Fat Maps: Microfluidics and Mass Spectrometry Illuminate Lipid Landscapes in Tiny Worms

August 22, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

APS PRESS Unveils Third Edition of Cotton Industry’s Premier Diagnostic Reference

Birth Weight Linked to Maternal, Neonatal PFOS Levels

β-Elemene’s Therapeutic Promise for Glioma, CNS Diseases

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.